Evidence map›Paper›PMID 35997496›Full record

ArticleEmerging infectious diseases2022

International Spread of Multidrug-Resistant Rhodococcus equi.

Jorge Val-Calvo, Jane Darcy, James Gibbons, Alan Creighton, Claire Egan, Thomas Buckley, Achim Schmalenberger, Ursula Fogarty, Mariela Scortti, José A Vázquez-Boland

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Integrated molecular and serological survey ofFrontiers in veterinary science · 2025
    Article
  6. Article
  7. Article
  8. Exploring the Accessory Genome of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jorge Val-Calvo
Jane Darcy
James Gibbons
Alan Creighton
Claire Egan
Thomas Buckley
Achim Schmalenberger
Ursula Fogarty
Mariela Scortti
José A Vázquez-Boland
University of Edinburgh · GBUniversity of Limerick · IEIrish Equine Centre · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multidrug-resistant clone of the animal and human pathogen Rhodococcus equi, MDR-RE 2287, has been circulating among equine farms in the United States since the 2000s. We report the detection of MDR-RE 2287 outside the United States. Our finding highlights the risk for MDR-RE spreading internationally with horse movements.

Indexed as

Actinomycetales InfectionsHorse DiseasesRhodococcus equiAnimalsAnti-Bacterial AgentsDrug Resistance, BacterialHorsesHumansMacrolidesRifampinUnited StatesAnti-Bacterial AgentsMacrolidesRifampinantimicrobial resistancebacteriaerm(46)macrolide resistanceMDR-REMDR R. equimultidrug-resistant Rhodococcus equipRErm46R. equi MDR 2287 cloneRhodococcus equirifampin resistanceTnRErm46United Stateszoonoses

Identifiers

PMID35997496
PMCPMC9423909
OpenAlexW4292615246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.